- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit
- Join Join
Governor Martin O'Malley signed HB 881 into law today, making Maryland the 21st medical marijuana state. The Maryland House of Delegates voted 125-11 last week to adopt HB 881, a medical marijuana bill that protect patients with severe pain, nausea, wasting syndrome, seizures, and severe muscle spasms from arrest and prosecution. Qualified patients will be able to obtain their medicine from licensed medical marijuana dispensaries, which will rely on licensed growers for their supply. Patients will be required to get approval from physicians who are approved by the state, and must obtain an identification card before they will be eligible to access a licensed dispensary.
"We're excited to welcome Maryland as the 21st medical marijuana state," said Mike Liszewski, Policy Director with Americans for Safe Access (ASA), who testified before House and Senate committees and helped ensure passage of the law. "Maryland's medical marijuana law will at long last provide patients with needed protection from arrest and prosecution, and give them a means to safely and legally obtain medical marijuana."
HB 881 was sponsored by Maryland House Delegate Cheryl Glenn (D-Baltimore) and co-sponsored by nearly half of the House. A broad coalition including ASA, industry stakeholders, and Stop the Seizures, a group of parents of children suffering from seizure disorders, worked tirelessly to pass HB 881. Several different versions of the bill were considered this year, and many amendments were added by Senator Jamie Raskin (D-Montgomery) to help patients navigate the program.
Maryland has struggled over the past few years to pass and implement medical marijuana legislation. In 2003, the Maryland legislature adopted the Darrel Putnam Compassionate Use Act, which was a skeletal medical marijuana law that provided an affirmative defense, but did not prevent patients from being arrested, prosecuted, or having to pay a fine, even if a defendant could prove they were a qualified patient. Last year, the legislature passed HB 1101, which established "Academic Medical Centers" to distribute marijuana to patients, but the untested program failed to gain buy-in from the state's academic institutions.
HB 881 establishes a new form of distribution. According to the new law, the Natalie M. LaPrade Medical Marijuana Commission, which was established under last year's legislation, will regulate dispensaries, characterized as an entity that "acquires, possesses, processes, transfers, transports, sells, distributes, dispenses, or administers marijuana, products containing food, tinctures, aerosols, oils, or ointments, or educational materials for use by a qualifying patient or a caregiver."